Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Glioblastoma”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Not applicableLooking for participantsNCT07627334
What this trial is testing

Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled for shOrt Course radiatioN

Who this might be right for
Glioblastoma (GBM)
Medical University of Vienna 30
Early research (Phase 1)Study completedNCT01324479
What this trial is testing

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals 131
Very early researchUnknownNCT05333588
What this trial is testing

The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.

Who this might be right for
Glioblastoma Multiforme, Adult
Hebei Senlang Biotechnology Inc., Ltd. 20
Early research (Phase 1)Study completedNCT04908176
What this trial is testing

A Drug-drug Interaction Study of Avapritinib and Midazolam

Who this might be right for
Gastrointestinal Stromal TumorsGISTNon-resectable Advanced Solid Tumors+1 more
Blueprint Medicines Corporation 10
Early research (Phase 1)Looking for participantsNCT06641908
What this trial is testing

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 65
Early research (Phase 1)Ended earlyNCT01508104
What this trial is testing

Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

Who this might be right for
Cancer
University of Cincinnati 19
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Early research (Phase 1)Study completedNCT01421524
What this trial is testing

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more
Celgene 271
Early research (Phase 1)Ended earlyNCT05831995
What this trial is testing

Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.

Who this might be right for
Advanced Solid TumorRAS MutationRAF Mutation+1 more
ABM Therapeutics Corporation 12
Testing effectiveness (Phase 2)Ended earlyNCT00959946
What this trial is testing

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Who this might be right for
Advanced Breast Cancer (Parts 1 and 2)Advanced Pancreatic Cancer (Part 1)Advanced Colorectal Cancer (Part 1)+2 more
Pfizer 32
Not applicableLooking for participantsNCT05911230
What this trial is testing

Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases

Who this might be right for
Glioblastoma (GBM)
University Hospital, Basel, Switzerland 10
Testing effectiveness (Phase 2)Ended earlyNCT02765165
What this trial is testing

Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Solid Tumors (Phase 1)Relapsed/Recurrent GBM (Phase 2)
Proximagen, LLC 26
Not applicableLooking for participantsNCT07636200
What this trial is testing

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

Who this might be right for
Advanced Solid Tumor CancerStage IV Cancer (Solid Tumors Only)Glioblastoma+2 more
University of Colorado, Boulder 250
Early research (Phase 1)Active Not RecruitingNCT05495295
What this trial is testing

First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours

Who this might be right for
Malignant TumorAdvanced Solid TumorGlioblastoma Multiforme+1 more
Phost'In Therapeutics 149
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Testing effectiveness (Phase 2)Study completedNCT04444427
What this trial is testing

Evaluation of GLR2007 for Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung CancerGlioblastoma Multiforme
Gan and Lee Pharmaceuticals, USA 19
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Next Page